Related Experiment Video
Updated: Aug 8, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Identification of epidermal growth factor receptor as a target of Cdc25A protein phosphatase
Ziqiu Wang1, Meifang Wang, John S Lazo
1Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.
Abstract:
Cdc25A, a dual-specificity protein phosphatase, plays a critical role in cell cycle progression. Although cyclin-dependent kinases are established substrates, Cdc25A may also affect other proteins. We have shown here that Cdc25A interacts with epidermal growth factor receptor (EGFR) both physically and functionally in Hep3B human hepatoma cells. Cdc25A inhibitor Cpd 5, a vitamin K analog, inhibited Cdc25A activity in the Cdc25A-EGFR immunocomplex and consequently caused prolonged EGFR tyrosine phosphorylation. Both purified GST-Cdc25A protein and endogenous Hep3B cellular Cdc25A dephosphorylated tyrosine-phosphorylated EGFR, and Cpd 5 antagonized the phosphatase activity of Cdc25A. A functional Cdc25A-EGFR interaction was seen in NR-6 fibroblasts expressing ectopic EGFR but not with a receptor lacking the C terminus or a mutated kinase domain. These data link the cell cycle control Cdc25A phosphatase to an EGFR-linked mitogenic signaling pathway specifically involving EGFR dephosphorylation.
Insights
Cdc25A phosphatase interacts with epidermal growth factor receptor (EGFR), influencing cell cycle and mitogenic signaling. Inhibiting Cdc25A prolongs EGFR tyrosine phosphorylation, linking cell cycle control to EGFR signaling.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Cdc25A is a dual-specificity protein phosphatase crucial for cell cycle progression.
- While known to dephosphorylate cyclin-dependent kinases, Cdc25A's broader substrate interactions are under investigation.
- Epidermal growth factor receptor (EGFR) signaling is vital for cell growth and proliferation.
Purpose of the Study:
- To investigate the physical and functional interaction between Cdc25A and EGFR.
- To determine the role of Cdc25A in regulating EGFR tyrosine phosphorylation.
- To elucidate the functional consequences of the Cdc25A-EGFR interaction on mitogenic signaling.
Main Methods:
- Co-immunoprecipitation assays to demonstrate physical interaction between Cdc25A and EGFR.
- In vitro phosphatase assays using purified GST-Cdc25A and cell lysates.
- Treatment with Cdc25A inhibitor Cpd 5 to assess its effect on EGFR phosphorylation.
- Functional studies in NR-6 fibroblasts expressing wild-type and mutant EGFR.
Main Results:
- Cdc25A physically and functionally interacts with EGFR in Hep3B human hepatoma cells.
- Cdc25A inhibitor Cpd 5 prolonged EGFR tyrosine phosphorylation by inhibiting Cdc25A activity within the Cdc25A-EGFR complex.
- Both purified and endogenous Cdc25A dephosphorylated tyrosine-phosphorylated EGFR.
- The interaction was dependent on the EGFR C terminus and kinase domain.
Conclusions:
- Cdc25A directly dephosphorylates tyrosine-phosphorylated EGFR.
- This dephosphorylation activity links Cdc25A's cell cycle regulatory function to EGFR-mediated mitogenic signaling.
- The findings reveal a novel role for Cdc25A in regulating growth factor receptor signaling pathways.
Related Concept Videos
Inhibition of Cdk Activity
Mitogens and the Cell Cycle
Amplifying Signals via Enzymatic Cascade
Receptor Tyrosine Kinases
PI3K/mTOR/AKT Signaling Pathway
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

